Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.
- Published In:
- Vaccine, 30(6), 1170-80 (2012)
- Authors:
- Carraro, G, Naso, A, Montomoli, E, Gasparini, R, Camerini, R, Panatto, D, Tineo, M C, De Giorgi, L, Piccirella, S, Khadang, B, Ceracchi, M, De Rosa, A
- Database ID:
- RPEP-01913
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01913APA
Carraro, G; Naso, A; Montomoli, E; Gasparini, R; Camerini, R; Panatto, D; Tineo, M C; De Giorgi, L; Piccirella, S; Khadang, B; Ceracchi, M; De Rosa, A. (2012). Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.. Vaccine, 30(6), 1170-80. https://doi.org/10.1016/j.vaccine.2011.12.014
MLA
Carraro, G, et al. "Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.." Vaccine, 2012. https://doi.org/10.1016/j.vaccine.2011.12.014
RethinkPeptides
RethinkPeptides Research Database. "Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an..." RPEP-01913. Retrieved from https://rethinkpeptides.com/research/carraro-2012-thymosinalpha-1-zadaxin-enhances
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.